Enters Transcatheter Mitral Valve Replacement (TMVR) space with unique design for its investigational device.
First Patient Enrolled in the PERSIST-AVR Trial at CHU Brabois, University of Lorraine, Nancy – France
LivaNova celebrates 100,000 patients enjoying more seizure-free moments with VNS Therapy.
LivaNova receives regulatory approval in Canada for its innovative Memo 3D ReChord annuloplasty ring for mitral valve repair
LivaNova receives regulatory approval in Japan for the Solo Smart stentless tissue aortic valve
LivaNova announces FDA approval of stented heart valve CROWN PRT ™ for aortic valve disease
Your Browser doesn't suport iframe
Our people, our purpose, and our solutions are transforming health and changing lives, worldwide.
Powered by Tamtamy
LivaNova PLC - Registered in England and Wales - Registered No. 09451374 - 20 Eastbourne Terrace, London, W2 6LG, United Kingdom